AUTO3 (CD19/22 CAR T cells
AUTO3-PA1
Phase 2 mab completed
Quick answer
AUTO3 (CD19/22 CAR T cells for B Acute Lymphoblastic Leukemia is a Phase 2 program (mab) at Autolus Therapeutics plc with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Autolus Therapeutics plc
- Indication
- B Acute Lymphoblastic Leukemia
- Phase
- Phase 2
- Modality
- mab
- Status
- completed